Answers are grounded in this paper and cite their sources.
In 1985-1986, a hepatitis B vaccination programme was conducted in a Belgian institution for the mentally handicapped. A group of 97 residents was followed up for 11 years in order to characterize the long-term persistence of hepatitis B antibodies after vaccination. This paper proposes the use of linear mixed-effects models to account for serial correlation and between-individual heterogeneity in the data, while adjusting the analysis for various individual characteristics and important risk factors in the response to vaccination. We propose several model building strategies and focus on the prediction of future levels of antibodies.
No takes yet. Share an insight, caveat, or question.
Renard et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: